Author supplied: The production system described in this paper in an implementation of an agile agent-based production system. This system is designed to meet the requirements of modern production, where short time to market, requirementdriven production and low cost small quantity production are important issues. The production is done on special devices called equiplets. A grid of these equiplets connected by a fast network is capable of producing a variety of different products in parallel. The multi-agent-based software infrastructure is responsible for the agile manufacturing. A product agent is responsible for the production of a single product and equiplet agents will perform the production steps to assemble the product. This paper describes this multiagent-based production system with the focus on the product agent. Presented at EUMAS 2013 ( 11th European Workshop on Multi-Agent Systems) , At Toulouse.
ABSTRACT When designing interventions for health, multidisciplinary teams increasingly work according to an ‘agile’ process. Potential benefits of this approach are better knowledge transfer, stakeholder inclusion, and removal of barriers to interactions. Unfortunately, the question whether agile approaches are useful in designing health interventions remains as yet unanswered. To contribute to current knowledge, we analysed the process and results of a large multidisciplinary project with an agile approach. Our case study shows such an approach may indeed be a feasible method for the development of health interventions. The process allowed for a high pace, and good stakeholder inclusion. Some limitations also occurred. The agile approach favours speed over rigour, which hinders integration of user research and scientific evidence in the development process. Multidisciplinary cooperation remains difficult because of the limited availability of experts and stakeholders. Finally, the difficulties in documenting the process and results of the agile approach limit its use in scientific projects. Published at https://research.shu.ac.uk/design4health/publications/2020-conference-proceedings Vol. 2
Abstract: Unlike manufacturing technology for semiconductors and printed circuit boards, the market for traditional micro assembly lacks a clear public roadmap. More agile manufacturing strategies are needed in an environment in which dealing with change becomes a rule instead of an exception. In this paper, an attempt is made to bring production with universal micro assembly cells to the next level. This is realised by placing a larger number of cells, called Equiplets, in a “Grid”. Equiplets are compact and low-cost manufacturing platforms that can be reconfigured to a broad number of applications. Benchmarking Equiplet production has shown reduced time to market and a smooth transition from R&D to Manufacturing. When higher production volumes are needed, more systems can be placed in parallel to meet the manufacturing demand. Costs of product design changes in the later stage of industrialisation have been reduced due to the modular production in grids, which allows the final design freeze to be postponed as late as possible. The need for invested capital is also pushed backwards accordingly. doi 10.1007/978-3-642-11598-1_32
LINK
